Essential Partners
HRMY icon

Essential Partners’s Harmony Biosciences HRMY Stock Holding History

Essential Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23K Buy
585
+14
+2% +$541 0.01% 860
2026
Q2 		$20.8K Buy
571
+197
+53% +$6.21K 0.01% 889
2026
Q1 		$10.5K Sell
374
-532
-59% -$17.4K ﹤0.01% 1234
2025
Q4 		$33.9K Buy
906
+3
+0.3% +$99 0.01% 723
2025
Q3 		$24.9K Buy
+903
New +$31.1K 0.01% 818

Other funds holding HRMY

CX Institutional
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Illumine Investment Management
Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return

Essential Partners's HRMY Position: Q3 2026 in Review

Essential Partners increased its Harmony Biosciences (HRMY) stake by 2.5% in Q3 2026, buying an estimated $541 and bringing the position to 585 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #860.

Essential Partners first reported a position in HRMY in Q3 2025 and has held it in 5 quarters since. The position peaked at $33.9K in Q4 2025. 48 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Essential Partners held 585 shares of Harmony Biosciences worth $23K as of Q3 2026.
  • Essential Partners bought 14 Harmony Biosciences shares in Q3 2026, an estimated $541.
  • Harmony Biosciences made up 0.01% of Essential Partners's portfolio in Q3 2026, its #860 holding.
  • Essential Partners first reported a position in Harmony Biosciences in Q3 2025 and has held it in 5 quarters since.
  • Essential Partners's Harmony Biosciences position peaked at $33.9K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.